Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Puma Biotechnology - 13 Year Stock Price History | PBYI

Historical daily share price chart and data for Puma Biotechnology since 2012 adjusted for splits and dividends. The latest closing stock price for Puma Biotechnology as of June 09, 2025 is 3.60.
  • The all-time high Puma Biotechnology stock closing price was 275.07 on September 18, 2014.
  • The Puma Biotechnology 52-week high stock price is 4.13, which is 14.7% above the current share price.
  • The Puma Biotechnology 52-week low stock price is 2.23, which is 38.1% below the current share price.
  • The average Puma Biotechnology stock price for the last 52 weeks is 3.05.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Puma Biotechnology Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 3.1302 3.1200 3.7400 2.7400 3.6000 18.03%
2024 3.9086 4.5250 7.4000 2.2500 3.0500 -29.56%
2023 3.4018 4.1300 4.8200 2.2100 4.3300 2.36%
2022 2.8637 3.1900 5.0800 1.6400 4.2300 39.14%
2021 8.2400 10.3300 13.6250 2.8500 3.0400 -70.37%
2020 10.0951 8.4300 14.5650 6.2800 10.2600 17.26%
2019 17.9948 21.6800 42.3700 6.5000 8.7500 -57.00%
2018 52.6096 92.6500 99.2500 20.0700 20.3500 -79.41%
2017 74.4849 31.5000 132.4500 29.0000 98.8500 221.99%
2016 42.5287 73.5400 73.5400 21.8700 30.7000 -60.84%
2015 140.9730 189.8600 249.7100 64.9700 78.4000 -58.58%
2014 154.7279 102.0600 275.0700 54.9900 189.2700 82.82%
2013 43.5442 19.0100 110.1000 18.9500 103.5300 452.16%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.179B $0.231B
Puma Biotechnology, Inc. is a small cancer biotech whose only marketed product, Nerlynx (neratinib) was launched in the United Statesfor the treatment of early stage HER2-positive breast cancer in patients who have been previously treated with Roche's Herceptin-based adjuvant therapy. The drug was also approved in the European Union. Nerlynx in combination with Roche's Xeloda was approved?by the Food and Drug Administration for third-line HER2-positive metastatic breast cancer. Meanwhile, several additional studies on Nerlynx targeting different types of breast cancer patient populations as well as other types of cancers are currently underway. A key analysis of Nerlynx is the phase II SUMMIT basket study for treating solid tumors in patients with activating EGFR, HER2 or HER4 mutated cancers. Puma markets Nerlynx in the United States and has several sub-licenses in various regions outside the United States to commercialize Nerlynx in some international markets.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $226.424B 16.90
Amgen (AMGN) United States $155.924B 13.97
Gilead Sciences (GILD) United States $140.564B 14.60
Vertex Pharmaceuticals (VRTX) United States $114.570B 0.00
Bristol Myers Squibb (BMY) United States $99.719B 6.68
GSK (GSK) United Kingdom $83.746B 10.02
CSL (CSLLY) Australia $76.835B 0.00
Regeneron Pharmaceuticals (REGN) United States $55.883B 13.56
Alnylam Pharmaceuticals (ALNY) United States $39.638B 0.00
Argenex SE (ARGX) Netherlands $35.636B 97.27
BioNTech SE (BNTX) Germany $26.196B 0.00
Biogen (BIIB) United States $19.657B 8.48
Royalty Pharma (RPRX) United States $18.773B 7.93
Genmab (GNMSF) Denmark $14.413B 14.74
Genmab (GMAB) Denmark $14.267B 16.01
Incyte (INCY) United States $13.529B 102.78
Illumina (ILMN) United States $13.452B 25.52
Insmed (INSM) United States $12.874B 0.00
Exelixis (EXEL) United States $11.705B 19.87
Swedish Orphan Biovitrum (BIOVF) Sweden $11.389B 29.08
BioMarin Pharmaceutical (BMRN) United States $10.908B 17.72
Moderna (MRNA) United States $10.883B 0.00
Ascendis Pharma (ASND) Denmark $10.578B 0.00
Exact Sciences (EXAS) United States $10.305B 0.00
QIAGEN (QGEN) Netherlands $10.263B 19.97
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.328B 0.00
Blueprint Medicines (BPMC) United States $8.265B 0.00
Bio-Techne Corp (TECH) United States $7.820B 29.17
Revolution Medicines (RVMD) United States $7.559B 0.00
Roivant Sciences (ROIV) United Kingdom $7.532B 0.00
Repligen (RGEN) United States $7.398B 82.82
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.206B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.769B 6.65
Halozyme Therapeutics (HALO) United States $6.701B 12.82
Legend Biotech (LEGN) United States $6.391B 0.00
TG Therapeutics (TGTX) United States $6.325B 166.00
Guardant Health (GH) United States $6.136B 0.00
Telix Pharmaceuticals (TLX) Australia $5.717B 0.00
Nuvalent (NUVL) United States $5.463B 0.00
Axsome Therapeutics (AXSM) United States $5.410B 0.00
Zealand Pharma (ZLDPF) Denmark $5.173B 0.00
Alkermes (ALKS) Ireland $5.135B 13.78
ADMA Biologics Inc (ADMA) United States $4.982B 37.27
Vaxcyte (PCVX) United States $4.799B 0.00
Akero Therapeutics (AKRO) United States $4.361B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.245B 0.00
Zai Lab (ZLAB) China $4.178B 0.00
PTC Therapeutics (PTCT) United States $4.097B 7.13
Cytokinetics (CYTK) United States $3.957B 0.00
Avidity Biosciences (RNA) United States $3.936B 0.00
Krystal Biotech (KRYS) United States $3.933B 30.31
Sarepta Therapeutics (SRPT) United States $3.903B 0.00
Merus (MRUS) Netherlands $3.801B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.732B 32.79
Arcellx (ACLX) United States $3.684B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.635B 0.00
SpringWorks Therapeutics (SWTX) United States $3.523B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.502B 0.00
Protagonist Therapeutics (PTGX) United States $3.451B 74.24
Scholar Rock Holding (SRRK) United States $3.235B 0.00
Alvotech (ALVO) Luxembourg $3.205B 18.33
Metsera (MTSR) United States $3.193B 0.00
Viking Therapeutics (VKTX) United States $3.096B 0.00
Kymera Therapeutics (KYMR) United States $3.071B 0.00
ImmunityBio (IBRX) United States $3.036B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.984B 0.00
Immunovant (IMVT) United States $2.784B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.782B 0.00
Ascentage Pharma Group - (AAPG) China $2.603B 0.00
Apellis Pharmaceuticals (APLS) United States $2.437B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.413B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.331B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.288B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.213B 0.00
Vericel (VCEL) United States $2.206B 1460.67
Bavarian Nordic (BVNRY) Denmark $2.166B 11.44
Denali Therapeutics (DNLI) United States $2.128B 0.00
Ligand Pharmaceuticals (LGND) United States $2.112B 0.00
CG Oncology (CGON) United States $2.058B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.034B 13.52
Twist Bioscience (TWST) United States $1.999B 0.00
Belite Bio (BLTE) United States $1.955B 0.00
Agios Pharmaceuticals (AGIO) United States $1.949B 0.00
Certara (CERT) United States $1.909B 35.67
IDEAYA Biosciences (IDYA) United States $1.901B 0.00
NovoCure (NVCR) Jersey $1.884B 0.00
Amicus Therapeutics (FOLD) United States $1.857B 201.00
Apogee Therapeutics (APGE) United States $1.848B 0.00
Beam Therapeutics (BEAM) United States $1.827B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.812B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.811B 0.00
Disc Medicine (IRON) United States $1.781B 0.00
Biohaven (BHVN) United States $1.743B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.694B 0.00
Edgewise Therapeutics (EWTX) United States $1.605B 0.00
Adaptive Biotechnologies (ADPT) United States $1.588B 0.00
89BIO (ETNB) United States $1.543B 0.00
Liquidia Technologies (LQDA) United States $1.540B 0.00
Janux Therapeutics (JANX) United States $1.535B 0.00
Mesoblast (MESO) Australia $1.514B 0.00
GRAIL (GRAL) United States $1.440B 0.00
Vera Therapeutics (VERA) United States $1.415B 0.00
Celldex Therapeutics (CLDX) United States $1.375B 0.00
ANI Pharmaceuticals (ANIP) United States $1.369B 14.10
MannKind (MNKD) United States $1.328B 27.31
Travere Therapeutics (TVTX) United States $1.324B 0.00
BGM Group (BGM) China $1.283B 0.00
Dynavax Technologies (DVAX) United States $1.234B 73.43
Viridian Therapeutics (VRDN) United States $1.212B 0.00
Anbio Biotechnology (NNNN) Germany $1.212B 0.00
Novavax (NVAX) United States $1.200B 2.80
Pacira BioSciences (PCRX) United States $1.177B 11.20
Structure Therapeutics (GPCR) United States $1.176B 0.00
WAVE Life Sciences (WVE) Singapore $1.087B 0.00
Niagen Bioscience (NAGE) United States $1.058B 149.22
Mineralys Therapeutics (MLYS) United States $1.055B 0.00
Arcus Biosciences (RCUS) United States $1.043B 0.00
Spyre Therapeutics (SYRE) United States $1.034B 0.00
Geron (GERN) United States $1.032B 0.00
CureVac (CVAC) Germany $1.005B 4.87
CorMedix Inc (CRMD) United States $0.973B 65.23
NeoGenomics (NEO) United States $0.973B 0.00
Nurix Therapeutics (NRIX) United States $0.956B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.954B 0.00
MiMedx (MDXG) United States $0.953B 23.04
Pharvaris (PHVS) Netherlands $0.943B 0.00
UniQure (QURE) Netherlands $0.926B 0.00
Praxis Precision Medicines (PRAX) United States $0.907B 0.00
LENZ Therapeutics (LENZ) United States $0.879B 0.00
Oculis Holding AG (OCS) Switzerland $0.870B 0.00
Zymeworks (ZYME) United States $0.866B 0.00
Intellia Therapeutics (NTLA) United States $0.858B 0.00
Nuvation Bio (NUVB) United States $0.854B 0.00
Pharming Group (PHAR) Netherlands $0.813B 0.00
ArriVent BioPharma (AVBP) United States $0.807B 0.00
Immunome (IMNM) United States $0.807B 0.00
Gyre Therapeutics (GYRE) United States $0.797B 212.50
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Cogent Biosciences (COGT) United States $0.786B 0.00
Replimune (REPL) United States $0.785B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Trevi Therapeutics (TRVI) United States $0.752B 0.00
Vir Biotechnology (VIR) United States $0.751B 0.00
AbCellera Biologics (ABCL) Canada $0.749B 0.00
Iovance Biotherapeutics (IOVA) United States $0.738B 0.00
Immatics (IMTX) Germany $0.729B 0.00
Sionna Therapeutics (SION) United States $0.726B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.718B 0.00
GH Research (GHRS) Ireland $0.713B 0.00
Oric Pharmaceuticals (ORIC) United States $0.701B 0.00
AnaptysBio (ANAB) United States $0.681B 0.00
Anavex Life Sciences (AVXL) United States $0.677B 0.00
Arbutus Biopharma (ABUS) United States $0.672B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Sana Biotechnology (SANA) United States $0.638B 0.00
Bicara Therapeutics (BCAX) United States $0.626B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.625B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.616B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.614B 0.00
Stoke Therapeutics (STOK) United States $0.608B 14.09
Upstream Bio (UPB) United States $0.607B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.591B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.586B 0.00
Dianthus Therapeutics (DNTH) United States $0.585B 0.00
Kura Oncology (KURA) United States $0.583B 0.00
Keros Therapeutics (KROS) United States $0.572B 0.00
Arvinas (ARVN) United States $0.572B 0.00
Maze Therapeutics (MAZE) United States $0.561B 0.00
Tyra Biosciences (TYRA) United States $0.545B 0.00
Opthea (OPT) Australia $0.525B 0.00
Castle Biosciences (CSTL) United States $0.525B 35.63
Cullinan Therapeutics (CGEM) United States $0.517B 0.00
MeiraGTx Holdings (MGTX) United States $0.508B 0.00
Zenas BioPharma (ZBIO) United States $0.499B 0.00
Fortrea Holdings (FTRE) United States $0.498B 13.75
Abivax SA (ABVX) France $0.495B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
Celcuity (CELC) United States $0.489B 0.00
ATyr Pharma (ATYR) United States $0.485B 0.00
Myriad Genetics (MYGN) United States $0.478B 0.00
REGENXBIO (RGNX) United States $0.478B 0.00
Rapport Therapeutics (RAPP) United States $0.464B 0.00
Erasca (ERAS) United States $0.462B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.459B 0.00
Tectonic Therapeutic (TECX) United States $0.457B 0.00
Tango Therapeutics (TNGX) United States $0.451B 0.00
Cytek Biosciences (CTKB) United States $0.451B 0.00
Septerna (SEPN) United States $0.450B 0.00
Precigen (PGEN) United States $0.443B 0.00
PureTech Health (PRTC) United States $0.440B 0.00
Sage Therapeutics (SAGE) United States $0.426B 0.00
Eton Pharmaceuticals (ETON) United States $0.425B 0.00
Benitec Biopharma (BNTC) United States $0.424B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.421B 0.00
Kamada (KMDA) Israel $0.401B 24.03
Northwest Biotherapeutics (NWBO) United States $0.399B 0.00
Humacyte (HUMA) United States $0.397B 0.00
Fulcrum Therapeutics (FULC) United States $0.384B 0.00
ITeos Therapeutics (ITOS) United States $0.384B 0.00
MBX Biosciences (MBX) United States $0.380B 0.00
Absci (ABSI) United States $0.379B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Rezolute (RZLT) United States $0.369B 0.00
Vigil Neuroscience (VIGL) United States $0.368B 0.00
Solid Biosciences (SLDB) United States $0.358B 0.00
Compass Therapeutics (CMPX) United States $0.355B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.354B 0.00
Emergent Biosolutions (EBS) United States $0.352B 0.00
Inventiva S.A (IVA) France $0.346B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.340B 0.00
Verastem (VSTM) United States $0.336B 0.00
Abeona Therapeutics (ABEO) United States $0.335B 0.00
Astria Therapeutics (ATXS) United States $0.327B 0.00
Terns Pharmaceuticals (TERN) United States $0.324B 0.00
Urogen Pharma (URGN) United States $0.324B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.322B 0.00
Cidara Therapeutics (CDTX) United States $0.318B 0.00
Ocugen (OCGN) United States $0.318B 0.00
Alpha Teknova (TKNO) United States $0.317B 0.00
Aura Biosciences (AURA) United States $0.316B 0.00
Allogene Therapeutics (ALLO) United States $0.308B 0.00
Entrada Therapeutics (TRDA) United States $0.308B 10.01
Monte Rosa Therapeutics (GLUE) United States $0.303B 61.50
XOMA Royalty (XOMA) United States $0.303B 0.00
Gossamer Bio (GOSS) United States $0.302B 0.00
Olema Pharmaceuticals (OLMA) United States $0.300B 0.00
Palvella Therapeutics (PVLA) United States $0.294B 0.00
Candel Therapeutics (CADL) United States $0.294B 0.00
Annexon (ANNX) United States $0.284B 0.00
Neurogene (NGNE) United States $0.284B 0.00
Prothena (PRTA) Ireland $0.283B 0.00
Cartesian Therapeutics (RNAC) United States $0.282B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.275B 0.00
Atea Pharmaceuticals (AVIR) United States $0.275B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.271B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.269B 0.00
Prima BioMed (IMMP) Australia $0.269B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Inozyme Pharma (INZY) United States $0.257B 0.00
Cardiff Oncology (CRDF) United States $0.257B 0.00
Foghorn Therapeutics (FHTX) United States $0.256B 0.00
Amarin (AMRN) Ireland $0.255B 0.00
Aardvark Therapeutics (AARD) United States $0.253B 0.00
Tvardi Therapeutics (TVRD) United States $0.252B 0.00
Lifecore Biomedical (LFCR) United States $0.251B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.243B 0.00
BioStem Technologies (BSEM) $0.239B 9.73
Third Harmonic Bio (THRD) United States $0.239B 0.00
DBV Technologies S.A (DBVT) France $0.238B 0.00
MaxCyte (MXCT) United States $0.232B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.230B 0.00
Instil Bio (TIL) United States $0.230B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
I-Mab (IMAB) United States $0.229B 0.00
Adherex Technologies (FENC) United States $0.228B 0.00
ScPharmaceuticals (SCPH) United States $0.224B 0.00
Design Therapeutics (DSGN) United States $0.222B 0.00
Prime Medicine (PRME) United States $0.219B 0.00
Kodiak Sciences (KOD) United States $0.219B 0.00
CARGO Therapeutics (CRGX) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
CytomX Therapeutics (CTMX) United States $0.212B 5.49
Monopar Therapeutics (MNPR) United States $0.212B 0.00
AC Immune (ACIU) Switzerland $0.211B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Inhibrx Biosciences (INBX) United States $0.208B 0.12
Semper Paratus Acquisition (TVGN) United States $0.202B 0.00
Codexis (CDXS) United States $0.197B 0.00
Bright Minds Biosciences (DRUG) United States $0.196B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.193B 0.00
Innate Pharma S.A (IPHA) France $0.192B 0.00
Voyager Therapeutics (VYGR) United States $0.185B 0.00
Nuvectis Pharma (NVCT) United States $0.185B 0.00
Ventyx Biosciences (VTYX) United States $0.182B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.179B 0.00
Neumora Therapeutics (NMRA) United States $0.176B 0.00
INmune Bio (INMB) United States $0.176B 0.00
DiaMedica Therapeutics (DMAC) United States $0.175B 0.00
Fate Therapeutics (FATE) United States $0.174B 0.00
Actuate Therapeutics (ACTU) United States $0.171B 0.00
EnGene Holdings (ENGN) Canada $0.171B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.166B 0.00
Anika Therapeutics (ANIK) United States $0.165B 0.00
23andMe Holding (MEHCQ) United States $0.164B 0.00
Sagimet Biosciences (SGMT) United States $0.164B 0.00
Alumis (ALMS) United States $0.162B 0.00
Editas Medicine (EDIT) United States $0.162B 0.00
Rapt Therapeutics (RAPT) United States $0.159B 0.00
Molecular Partners AG (MOLN) Switzerland $0.157B 0.00
Galena Biopharma (SLS) United States $0.157B 0.00
Spero Therapeutics (SPRO) United States $0.154B 0.00
BioAge Labs (BIOA) United States $0.154B 0.00
Agenus (AGEN) United States $0.152B 0.00
Compugen (CGEN) Israel $0.152B 0.00
Kyverna Therapeutics (KYTX) United States $0.149B 0.00
Alpha Cognition (ACOG) Canada $0.147B 0.00
Alector (ALEC) United States $0.144B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.142B 0.00
Black Diamond Therapeutics (BDTX) United States $0.141B 41.33
Nkarta (NKTX) United States $0.133B 0.00
Seer (SEER) United States $0.130B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.128B 0.00
Elicio Therapeutics (ELTX) United States $0.128B 0.00
Greenwich LifeSciences (GLSI) United States $0.126B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.126B 0.00
TuHURA Biosciences (HURA) United States $0.126B 0.00
Cabaletta Bio (CABA) United States $0.120B 0.00
Theratechnologies (THTX) Canada $0.120B 0.00
C4 Therapeutics (CCCC) United States $0.119B 0.00
Sangamo Therapeutics (SGMO) United States $0.119B 0.00
Caribou Biosciences (CRBU) United States $0.118B 0.00
EXoZymes (EXOZ) United States $0.117B 0.00
Invivyd (IVVD) United States $0.116B 0.00
Contineum Therapeutics (CTNM) United States $0.116B 0.00
BioHarvest Sciences (BHST) Canada $0.115B 0.00
Tenaya Therapeutics (TNYA) United States $0.111B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.110B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.107B 0.00
HilleVax (HLVX) United States $0.102B 0.00
Genelux (GNLX) United States $0.102B 0.00
IO Biotech (IOBT) Denmark $0.102B 0.00
TScan Therapeutics (TCRX) United States $0.100B 0.00
Coherus BioSciences (CHRS) United States $0.099B 0.00
Biomea Fusion (BMEA) United States $0.099B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
Pliant Therapeutics (PLRX) United States $0.098B 0.00
Nautilus Biotechnology (NAUT) United States $0.097B 0.00
Entera Bio (ENTX) Israel $0.096B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.094B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.094B 0.00
Whitehawk Therapeutics (WHWK) United States $0.092B 0.00
Climb Bio (CLYM) United States $0.091B 0.00
Adagene (ADAG) China $0.090B 0.00
XBiotech (XBIT) United States $0.090B 0.00
Jasper Therapeutics (JSPR) United States $0.089B 0.00
BeyondSpring (BYSI) United States $0.089B 0.00
Citius Oncology (CTOR) United States $0.088B 0.00
Zura Bio (ZURA) United States $0.085B 0.00
Immunic (IMUX) United States $0.083B 0.00
Inovio Pharmaceuticals (INO) United States $0.081B 0.00
Senti Biosciences (SNTI) United States $0.081B 0.00
Cellectis S.A (CLLS) France $0.079B 0.00
Forte Biosciences (FBRX) United States $0.079B 0.00
PDS Biotechnology (PDSB) United States $0.078B 0.00
Immuneering (IMRX) United States $0.078B 0.00
Elutia (ELUT) United States $0.078B 0.00
IGM Biosciences (IGMS) United States $0.077B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.077B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.075B 0.00
TELA Bio (TELA) United States $0.074B 0.00
Genenta Science S.p.A (GNTA) Italy $0.073B 0.00
Skye Bioscience (SKYE) United States $0.072B 0.00
Seres Therapeutics (MCRB) United States $0.071B 0.00
OKYO Pharma (OKYO) $0.071B 0.00
Ikena Oncology (IKNA) United States $0.071B 0.00
Sutro Biopharma (STRO) United States $0.070B 0.00
MediciNova (MNOV) United States $0.070B 0.00
Alto Neuroscience (ANRO) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.068B 0.00
CervoMed (CRVO) United States $0.067B 0.00
ZIVO Bioscience (ZIVO) United States $0.066B 0.00
Immix Biopharma (IMMX) United States $0.065B 0.00
Oncobiologics (OTLK) United States $0.064B 0.00
Adicet Bio (ACET) United States $0.064B 0.00
Werewolf Therapeutics (HOWL) United States $0.063B 0.00
Repare Therapeutics (RPTX) Canada $0.063B 0.00
Fortress Biotech (FBIO) United States $0.063B 0.00
Opus Genetics (IRD) United States $0.063B 0.00
Adverum Biotechnologies (ADVM) United States $0.062B 0.00
Renovaro (RENB) United States $0.062B 0.00
Exicure (XCUR) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Annovis Bio (ANVS) United States $0.060B 0.00
Adlai Nortye (ANL) Cayman Islands $0.059B 0.00
Clearside Biomedical (CLSD) United States $0.059B 0.00
Precision BioSciences (DTIL) United States $0.059B 0.00
Kalaris Therapeutics (KLRS) United States $0.057B 0.00
InflaRx (IFRX) Germany $0.057B 0.00
Shattuck Labs (STTK) United States $0.057B 0.00
Applied Therapeutics (APLT) United States $0.056B 0.00
Akoya Biosciences (AKYA) United States $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Quince Therapeutics (QNCX) United States $0.053B 0.00
Kronos Bio (KRON) United States $0.053B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Artiva Biotherapeutics (ARTV) United States $0.051B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
PepGen (PEPG) United States $0.050B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Mersana Therapeutics (MRSN) United States $0.049B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Celularity (CELU) United States $0.047B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.045B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
Rein Therapeutics (RNTX) United States $0.044B 0.00
Connect Biopharma Holdings (CNTB) United States $0.043B 0.00
Scilex Holding (SCLX) United States $0.043B 0.00
Alterity Therapeutics - (ATHE) Australia $0.043B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Quantum Biopharma (QNTM) Canada $0.041B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.040B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Medicus Pharma (MDCX) United States $0.039B 0.00
OnKure Therapeutics (OKUR) United States $0.039B 0.00
Oncolytics Biotech (ONCY) Canada $0.039B 0.00
Clene (CLNN) United States $0.038B 0.00
CAMP4 Therapeutics (CAMP) United States $0.037B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Radiopharm Theranostics - (RADX) Australia $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
FibroBiologics (FBLG) United States $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Pluri (PLUR) Israel $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.034B 0.00
Rani Therapeutics Holdings (RANI) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Grace Therapeutics (GRCE) Canada $0.032B 0.00
ALX Oncology Holdings (ALXO) United States $0.031B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.031B 0.00
Allakos (ALLK) United States $0.030B 0.00
BioAtla (BCAB) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.030B 0.00
Passage Bio (PASG) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Vor Biopharma (VOR) $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
ABVC BioPharma (ABVC) United States $0.028B 0.00
Generation Bio (GBIO) United States $0.027B 0.00
KALA BIO (KALA) United States $0.027B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
CalciMedica (CALC) United States $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
X4 Pharmaceuticals (XFOR) United States $0.024B 0.00
Ovid Therapeutics (OVID) United States $0.024B 0.00
Imunon (IMNN) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Q32 Bio (QTTB) United States $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.022B 0.00
Femasys (FEMY) United States $0.020B 0.00
Advanced Biomed (ADVB) United States $0.020B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.020B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.020B 0.00
Cingulate (CING) United States $0.019B 0.00
Longeveron (LGVN) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Leap Therapeutics (LPTX) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Rallybio (RLYB) United States $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
NextCure (NXTC) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
Aytu BioPharma (AYTU) United States $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Athira Pharma (ATHA) United States $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Eyenovia (EYEN) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
UNITY Biotechnology (UBX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
IN8bio (INAB) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
Apollomics (APLM) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00